Evidence map›Paper›PMID 8668543›Full record

ArticleNucleic acids research1996

Transcriptional activation by Oct-3: evidence for a specific role of the POU-specific domain in mediating functional interaction with Oct-1.

M A Vigano, L M Staudt

Abstract read
In one paragraph

Article in Nucleic acids research, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Review
  2. Phosphorylation of ThreonineStem cell reports · 2017
    Article
  3. Article
  4. Article
  5. Distinct functions of acj6 splice forms in odor receptor gene choice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2010
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

M A ViganoDIBIT-Istituto Scientifico H.S. Raffaele, Milano, Italy.
L M Staudt

Funding

Telethon TGT06S01Telethon TGT95000
6 · The paper itself

Abstract

Oct-3, a member of the POU family of transcription factors, is expressed in pluripotent cells of early mammalian embryos and in undifferentiated embryonal carcinoma cell lines. Using a variety of Oct-3 mutants, we have identified two different domains of Oct-3 which activate transcription in transfected mammalian cells. One of these domains, located in the C-terminal part of the protein, plays a major role in transcriptional activation when Oct-3 is bound to its cognate site, the octamer motif. An Oct-3 mutant containing a single amino acid substitution in the POU homeodomain is unable to bind the octamer target in vitro, yet is still able to activate transcription in an octamer-dependent manner. We provide evidence that transactivation by this mutant involves protein-protein interactions with the ubiquitous octamer binding factor Oct-1. This interaction requires the POU-specific domain of Oct-3 and allows recruitment of Oct-3 to the target promoter even in the absence of Oct-3 DNA binding.

Indexed as

Saccharomyces cerevisiae Proteins3T3 CellsAnimalsDNA-Binding ProteinsDrug InteractionsFungal ProteinsGene ExpressionHeLa CellsHost Cell Factor C1HumansMiceMutagenesis, Site-DirectedOctamer Transcription Factor-1Octamer Transcription Factor-3PlasmidsPolymerase Chain ReactionDNA-Binding ProteinsFungal ProteinsGAL4 protein, S cerevisiaeHCFC1 protein, humanHcfc1 protein, mouseHost Cell Factor C1Octamer Transcription Factor-1Octamer Transcription Factor-3POU2F1 protein, humanPou2f1 protein, mousePOU5F1 protein, humanPou5f1 protein, mouseRecombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsTranscription Factors

Identifiers

PMID8668543
PMCPMC145896

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.